The retina comprises seven major cell types, each of which is required for normal visual function. Photoreceptors detect light stimuli and transmit this information to bipolar cell interneurons. Bipolar cells relay signals to retinal ganglion cell (RGC) neurons that project to the brain. Owing to the complexity of visual information that must be processed, most retinal cell types are further specialized into subtypes with discrete functions, morphologies, and molecular characteristics. Bipolar cells have considerable subtype diversity. In mice, 14 bipolar cell subtypes are categorized based on how they synapse with photoreceptors, their physiology, and their dendritic and axonal morphologies.^[@i1552-5783-58-2-1137-b01][@i1552-5783-58-2-1137-b02][@i1552-5783-58-2-1137-b03]--[@i1552-5783-58-2-1137-b04]^ Rod bipolar cells synapse with rod photoreceptors and are activated by dim light signals. The remaining 13 bipolar subtypes preferentially synapse with cones. Five OFF subtypes (1, 2, 3a, 3b, 4) depolarize upon the loss of photic stimuli and the tips of their axons are localized to the outer-half of the inner plexiform layer (IPL). Eight ON subtypes (5i, 5o, 5t, XBC, 6, 7, 8, and 9) typically depolarize at the onset of light stimuli and their axons ramify in the inner-half of the IPL.^[@i1552-5783-58-2-1137-b01][@i1552-5783-58-2-1137-b02][@i1552-5783-58-2-1137-b03]--[@i1552-5783-58-2-1137-b04]^ Together, these bipolar subtypes make up approximately 7% of the cells in the mouse retina.^[@i1552-5783-58-2-1137-b05]^ The fundamental question of how bipolar cell diversity is programmed during development remains only partially answered.

Bipolar cells permanently exit the cell cycle late in mouse retinal development, starting around the time of birth and continuing to roughly postnatal day (P)7.^[@i1552-5783-58-2-1137-b06][@i1552-5783-58-2-1137-b07][@i1552-5783-58-2-1137-b08]--[@i1552-5783-58-2-1137-b09]^ Loss-of-function experiments have shown that the transcription factors *Otx2* and *Vsx2* (*Chx10*) are necessary for bipolar cell development.^[@i1552-5783-58-2-1137-b10][@i1552-5783-58-2-1137-b11][@i1552-5783-58-2-1137-b12]--[@i1552-5783-58-2-1137-b13]^ Otx2 is required for the formation of multiple cell types during retinogenesis and marks bipolar cells and photoreceptors in the mature mouse retina.^[@i1552-5783-58-2-1137-b12][@i1552-5783-58-2-1137-b13]--[@i1552-5783-58-2-1137-b14]^ Vsx2 is expressed by all proliferative retinal progenitors, but it is not robustly expressed in postmitotic cells until P4.^[@i1552-5783-58-2-1137-b15],[@i1552-5783-58-2-1137-b16]^ Indeed, definitive bipolar markers are not appreciably seen until P4 or later,^[@i1552-5783-58-2-1137-b16]^ demonstrating a temporal gap between cell cycle exit and differentiation. Vsx2 has been shown to repress photoreceptor gene expression, arguing that it is permissive for bipolar cell development.^[@i1552-5783-58-2-1137-b17],[@i1552-5783-58-2-1137-b18]^ The transcription factors *Ascl1* and *Neurod4* (*Math3*) are made in proliferative progenitors and/or postmitotic precursor cells. *Ascl1* or *Neurod4* overexpression along with *Vsx2* can generate excess bipolar cells.^[@i1552-5783-58-2-1137-b19]^ The combined loss of *Ascl1* and *Neurod4* strongly reduces bipolar cell formation.^[@i1552-5783-58-2-1137-b20],[@i1552-5783-58-2-1137-b21]^ Due to limited marker availability, whether *Ascl1* and *Neurod4* combine to regulate bipolar cell fate choice as an entire group or whether they control specific subtype genesis is unclear. Other transcription factors involved in bipolar development, including *Bhlhb4*, *Bhlhb5* (*Bhlhe22*), *Isl1*, *Lhx3*, *Lhx4*, *Prdm8*, and *Vsx1*, appear to be expressed in postmitotic committed bipolar cells.^[@i1552-5783-58-2-1137-b16],[@i1552-5783-58-2-1137-b22][@i1552-5783-58-2-1137-b23][@i1552-5783-58-2-1137-b24][@i1552-5783-58-2-1137-b25][@i1552-5783-58-2-1137-b26][@i1552-5783-58-2-1137-b27][@i1552-5783-58-2-1137-b28][@i1552-5783-58-2-1137-b29][@i1552-5783-58-2-1137-b30][@i1552-5783-58-2-1137-b31][@i1552-5783-58-2-1137-b32][@i1552-5783-58-2-1137-b33]--[@i1552-5783-58-2-1137-b34]^ Loss-of-function analysis suggests that these genes control bipolar cell subtype choice or differentiation. For example, *Bhlhb4* deletion causes the progressive loss of rod bipolar cells while *Bhlhb5* mutants do not form type 2 cone bipolar cells.^[@i1552-5783-58-2-1137-b23],[@i1552-5783-58-2-1137-b24],[@i1552-5783-58-2-1137-b27]^ Together, these data provide only a partial explanation for the mechanisms that control bipolar cell commitment and subtype choice.

A major barrier to uncovering the mechanisms of bipolar cell development is a lack of early pan and subtype-specific markers. Mice lacking the transcription factor *Blimp1* (*Prdm1*) generate excess bipolar cells at the expense of photoreceptors.^[@i1552-5783-58-2-1137-b15],[@i1552-5783-58-2-1137-b35],[@i1552-5783-58-2-1137-b36]^ Bipolar cells are formed precociously in *Blimp1* conditional knock-out (CKO) retinas. We compared gene expression in *Blimp1* CKO retinas to controls at P2, which precedes normal bipolar-specific gene expression onset. This provided a sensitive assay for the unbiased detection of early bipolar-specific factors by RNA sequencing (RNA-seq). This profiling technique was sensitive and robust; we identified several known genes and approximately two dozen novel candidate bipolar-specific factors. We characterized the expression of three of these candidates in more detail. Candidate genes *Gsg1*, *Trnp1*, and *Tmem215* were expressed in discrete subsets of bipolar cells, broadening the portfolio of markers that describe developing bipolar cells. The characterization of the remaining candidate genes is likely to increase this portfolio even further. The specificity and timing of *Gsg1*, *Trnp1*, and *Tmem215* suggests that they regulate different aspects of bipolar subtype choice and differentiation.

Materials and Methods {#s2}
=====================

Animals {#s2a}
-------

Heterozygous *Blimp1* (*αPax6-Cre-IRES-GFP::Blimp1^Flox/+^*) control and conditional knockout (CKO) (*αPax6-Cre-IRES-GFP::Blimp1^Flox/Flox^*) mice were generated and genotyped as previously described.^[@i1552-5783-58-2-1137-b15]^ These mice were used at P2, P5, and P7 for RNA-seq, RT-PCR, and histologic techniques (below). Wild-type *C57BL/6J* mice (strain \#664, Jackson Laboratories, Bar Harbor, ME, USA) were used for histology at multiple ages. To generate *Tmem215-LacZ* gene trap mice, cryopreserved (*Tmem215^tm1(KOMP)Vlcg^*) heterozygous embryos from the Knockout Mouse Project (KOMP)^[@i1552-5783-58-2-1137-b37]^ repository were acquired from the Mutant Mouse Regional Resource Center (University of California Davis, Davis, CA, USA). The embryos were rederived by the University of Colorado Denver Bioengineering Core and the resulting animals were crossed to *C57BL/6J* mice. The allele *Tmem215-LacZ* was detected by PCR with the following primers at 60°C annealing: 5′-GTCTGTCCTAGCTTCCTCACTG and 5′-GTCAGAGATAGCAAGAAAGAG, yielding a 279-bp product. *Tmem215-LacZ* heterozygous mice were used for histology or crossed to *Blimp1* CKO mice to generate *Tmem215-LacZ::αPax6-Cre-IRES-GFP::Blimp1^Flox/Flox^* animals. All animals were used in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and with the approval of the University of Colorado Denver IACUC.

RNA Sequencing {#s2b}
--------------

We collected eyes from five P2 *Blimp1* CKO and heterozygous control mice. From each animal, one retina was dissected in PBS and homogenized in 0.5 mL TRIzol (Thermo Fisher Scientific, Waltham, MA, USA). The other eye was processed for immunohistochemistry (below) and the presence or absence of Blimp1 confirmed by immunostaining. Total RNA was purified from TRIzol according to the manufacturer\'s instructions. We further purified the RNA using a commercial kit (RNeasy; Qiagen, Valencia, CA, USA) according the manufacturer\'s protocol. Total RNA was submitted to the University of Colorado Genomics and Microarray Core Facility for quality control and labeling. The 10 samples were labeled with unique barcodes for RNA-seq using a commercial kit (Illumina TruSeq mRNA Library Preparation Kit; Illumina, San Diego, CA, USA). Samples were sequenced in 1 × 100 mode on a sequencing instrument (Illumina HiSeq 2000; Illumina) to generate approximately 20 million informative fragments per sample. Sequencing of RNA was analyzed by applying a custom computational pipeline consisting of the open-source gSNAP, Cufflinks, and R for sequence alignment and ascertainment of differential gene expression.^[@i1552-5783-58-2-1137-b38][@i1552-5783-58-2-1137-b39][@i1552-5783-58-2-1137-b40]--[@i1552-5783-58-2-1137-b41]^ Reads of RNA were aligned to the mouse genome (MM9) by gSNAP; expression (fragments per kilobase exon per million mapped reads \[FPKM\]) derived by Cufflinks; and differential expression analyzed with ANOVA in R. We used the following criteria to define bipolar-specific gene candidates: upregulated \>1.45-fold versus heterozygous controls, expression \>1 FPKM in *Blimp1* CKO samples, false discovery rate (FDR) \<0.45, and *P* \< 0.05.

Reverse Transcription PCR {#s2c}
-------------------------

We dissected the retinas from three P2 *Blimp1* CKO and heterozygous control mice in PBS and homogenized each pair of retinas separately in 0.5 mL TRIzol. Total RNA was purified as above and treated with commercial endonuclease (RNase-free DNase; Promega, Madison, WI, USA) for 1 hour; the six samples were further purified with a RNeasy kit, as described above. Reverse transcription was done using a complementary DNA synthesis kit according to the manufacturer\'s protocol (iScript; Bio-Rad Laboratories, Inc., Temecula, CA, USA). We conducted RT-PCR with primers to candidate and house-keeping genes (for primers, see [Supplementary Table S2](#iovs-58-02-09_s02){ref-type="supplementary-material"}) using Sso Fast Supermix (Bio-Rad Laboratories, Inc.) and a CFX Connect thermocycler (Bio-Rad Laboratories, Inc.) according to the manufacturer\'s instructions. Expression differences were calculated using the ΔΔCt method.^[@i1552-5783-58-2-1137-b42]^ Differences were compared using unpaired Student\'s *t*-tests. We considered *P* \< 0.05 to be statistically significant.

Immunohistochemistry {#s2d}
--------------------

Retinal tissue was fixed in 2% paraformaldehyde (PFA) for 1 to 2 hours at room temperature, cryopreserved through 30% sucrose, frozen in OCT (Sakura, Torrance, CA, USA), and cryosectioned at 10 to 12 μm thickness. For immunostaining, sections were blocked in a previously described solution containing 5% milk and 0.5% Triton X-100^15^ for 2 to 4 hours at room temperature. The sections were incubated with primary antibodies (below) diluted in milk block solution for 12 to 18 hours at room temperature. Fluorescently conjugated secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA) diluted in milk block solution were added to the sections for one hour at room temperature. Primary antibodies used were: mouse anti-Ap2α (1:250, clone 5E4; Developmental Studies Hybridoma Bank, Iowa City, IA, USA); chicken anti--β-galactosidase (β-gal; 1:2000, AB9361; Abcam, Cambridge, MA, USA); goat anti-Bhlhb5 (1:1000, sc-6045; Santa Cruz Biotechnology, Inc., Dallas, TX, USA); mouse anti-Cabp5 (1:10, a gift from F. Haeseleer, University of Washington)^[@i1552-5783-58-2-1137-b43]^; mouse anti-Calretinin (1:750) (MAB1568, Milipore, Billerica, MA, USA); mouse anti-Calsenilin (1:2000, 05-756; Milipore); rabbit anti-GAD65/67 (1:500, AB1511; Milipore); goat anti-GlyT1 (1:2000, AB1770; Milipore); rabbit anti-HCN4 (1:500, APC-052; Alomone Labs Ltd., Jerusalem, Israel); mouse anti-Isl1/2 (1:250, clone 39.4D5; Developmental Studies Hybridoma Bank); goat anti-Otx2 (1:200, BAF1979; R&D Systems, Minneapolis, MN, USA); rabbit anti-Pax6 (1:500, 901301; BioLegend, Inc., San Diego, CA, USA); mouse anti-PKARIIβ (1:3000, 610625; BD Biosciences, San Jose, CA, USA); mouse anti-PKCα (1:250, P5704; Sigma-Aldrich Corp., St. Louis, MO, USA); rabbit anti-Scgn (1:5000, RD181120100; Biovendor LLC, Ashville, NC, USA); goat anti-Sox2 (1:100, sc17320; Santa Cruz Biotechnology); guinea pig anti-Trnp1 (1:200, a gift from M. Götz, Helmholtz Zentrum Muenchen)^[@i1552-5783-58-2-1137-b44]^; and rabbit anti-Vsx1 (1:250, a gift from E. Levine, Vanderbilt University).^[@i1552-5783-58-2-1137-b31]^ We used a laser scanning confocal microscope (C2+; Nikon Instruments, Inc., Melville, NY, USA) to acquire 1024 × 1024 pixel photographs of retinal sections one laser line at a time. Three to five *z*-stacks (1--1.5 μm per slice) were acquired and minimally processed with ImageJ (<http://imagej.nih.gov/ij/>; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA)^[@i1552-5783-58-2-1137-b45]^ and a raster graphics editor (Photoshop; Adobe Systems, Inc., San Jose, CA, USA) to generate maximum intensity *z*-stack projections. Marker overlaps were secondarily verified by examining the XZ and YZ orthogonal projections of the images. For quantification of Trnp1 immunostaining, 3108 Trnp1+ cells were counted from 107 adult C57BL/6J sections representing six eyes costained with amacrine- and bipolar-specific markers. For quantification of *Tmem215-LacZ*, 4680 β-gal+ cells were counted from 141 sections of four adult *Tme215-LacZ* heterozygous mice. For adult *Gsg1* in situ experiments (below), 209 Scgn+ cells (five sections, two mice) and 138 Cabp5+ cells (four sections, two mice) were scored for the presence or absence of *Gsg1* fluorescent puncta.

In Situ Hybridization {#s2e}
---------------------

Wild-type *C57BL/6* and *Blimp1* CKO retinas from 3 to 10 animals were used for in situ hybridization at multiple ages. We used a tissue assay kit (ViewRNA ISH; Affymetrix, Santa Clara, CA, USA) with a signal amplification kit (ViewRNA Chromogenic; Affymetrix) for single-plex fluorescent detection of mRNA. Custom probes to genes of interest were acquired from Affymetrix (ViewRNA Type I). In situ hybridization was conducted on 12-μm cryosections (see above) according to the manufacturer\'s instructions, but with some modifications as conditions needed to be optimized for each probe. For *Tmem215* (VB1-15511-01; Affymetrix), sections were fixed for 16.5 hours in 4% PFA at 4°C, incubated in protease solution for 10 minutes, hybridized with probe for 3 hours, and developed with Fast-Red substrate for 40 minutes. For *Trnp1* (VB1-16821-01; Affymetrix), sections were fixed for 1.5 hours in 4% PFA at room temperature, protease treated for 10 minutes, hybridized for 2.5 hours, and developed with Fast-Red for 40 minutes. For *Slitrk6* (VB1-15510-01; Affymetrix), sections were fixed for 16.5 hours in 4% PFA at 4°C, treated with protease for 15 minutes, hybridized for 3 hours, and developed with Fast-Red for 30 minutes. For *Gsg1* (VB1-17855-01; Affymetrix), sections were fixed for 30 minutes with 4% PFA at room temperature, protease treated for 10 minutes, incubated with probe for 3 hours, and developed for 40 minutes with Fast-Red. After the in situ hybridization, sections were counterstained with DAPI (4′,6-diamidino-2-phenylindole) or immunostained as described above. The number, intensity, and size of Fast-Red positive puncta varied between retinal sections and animals, but the overall spatial pattern was reproducible. Puncta tended to be localized within and near the cell nucleus, making quantification with nuclear markers problematic. Immunostaining sections first was incompatible with the in situ protocol. Sections of *Blimp1* CKO adjacent to those used for in situ were separately immunostained for Blimp1 (see above) to establish the rough extent of the knock-out domain of the peripheral retina. This typically amounted to approximately one half of the total retinal length in a given section.

Results {#s3}
=======

Identification of Genes Differentially Regulated in *Blimp1* Mutant Retinas {#s3a}
---------------------------------------------------------------------------

The genes that regulate bipolar cell genesis and subtype formation are poorly understood. In mice that lack *Blimp1* (*Prdm1*), roughly three times more bipolar cell interneurons are generated at the expense of photoreceptors during development.^[@i1552-5783-58-2-1137-b15],[@i1552-5783-58-2-1137-b36]^ Starting around birth, bipolar-specific genes become precociously expressed in these mutants.^[@i1552-5783-58-2-1137-b15],[@i1552-5783-58-2-1137-b36]^ Since definitive bipolar markers are not observed until approximately P4 in wild-type mice,^[@i1552-5783-58-2-1137-b16]^ we reasoned that genes upregulated in *Blimp1* mutant retinas prior to P4 would specifically mark and/or promote bipolar cell development. We therefore decided to examine gene expression at P2, roughly 2 days after precocious bipolar gene expression onset in *Blimp1* mutants, but still well before their onset in wild-type retinas.

To identify the full repertoire of precocious genes, we compared the transcriptome of *αPax6-Cre-IRES-GFP;Blimp1^Flox/+^* (heterozygous, control) and *αPax6-Cre-IRES-GFP;Blimp1^Flox/Flox^* (CKO, experimental) retinas at P2 by RNA sequencing ([Fig. 1](#i1552-5783-58-2-1137-f01){ref-type="fig"}). In these mice, the peripheral part of the retina expresses Cre recombinase. Thus, peripheral retinas lack either one or both *Blimp1* alleles, while the central retina remains essentially wild-type ([Fig. 1](#i1552-5783-58-2-1137-f01){ref-type="fig"}). We collected RNA from the entire retinas from five eyes of each genotype for RNA-seq analysis. After mapping sequencing reads to genes and normalizing for sequencing depth and transcript length (FPKM), the average expression values for each gene were calculated. Overall, the variability in expression values between replicates was modest ([Supplementary Table S1](#iovs-58-02-19_s01){ref-type="supplementary-material"}). Next, the ratio between mutant and heterozygous retinas was calculated and converted to fold change ([Supplementary Table S1](#iovs-58-02-19_s01){ref-type="supplementary-material"}). We reasoned that fold-change values that are significantly greater than 1 represent bipolar-specific genes while those significantly less than −1 represent photoreceptor-specific genes ([Fig. 1](#i1552-5783-58-2-1137-f01){ref-type="fig"}). We anticipated difficulty detecting downregulated genes because the wild-type areas of the retina in each sample robustly express several photoreceptor markers at P2, diluting the changes seen by *Blimp1* loss-of-function. Nonetheless, we identified 40 genes that were significantly reduced more than 1.5-fold in mutants compared to heterozygous controls (*P* \< 0.05, FDR \< 0.45; [Table 1](#i1552-5783-58-2-1137-t01){ref-type="table"}). Despite a lower power to detect downregulated genes in this experiment, we observed a clear decrease in *Blimp1* (*Prdm1*) expression in mutants ([Table 1](#i1552-5783-58-2-1137-t01){ref-type="table"}). As expected, the majority of these downregulated factors were rod and cone photoreceptor-specific genes like *Arr3*, *Pde6b*, *Rho*, *Thrb*, and *Cnga1* (bold text, [Table 1](#i1552-5783-58-2-1137-t01){ref-type="table"}). We did not anticipate difficulty identifying upregulated genes in this experiment because few bipolar genes are expressed in wild-type retinas at this age. We observed 40 genes that were significantly upregulated more than 1.45-fold in mutants compared to heterozygous controls (*P* \< 0.05, FDR \< 0.45; [Table 2](#i1552-5783-58-2-1137-t02){ref-type="table"}). As predicted, several of these genes are known markers of bipolar cells such as *Vsx1*, *Vsx2*, *Scgn*, *Lhx3*, *Lhx4*, *Fezf2*, *Grm6*, *Isl1*, and *Bhlhb5 (Bhlhe22*; bold text, [Table 2](#i1552-5783-58-2-1137-t02){ref-type="table"}). Several of the other upregulated genes in this list have not been characterized in the retina and in some cases, any other tissues. We next validated a subset of these upregulated genes by quantitative RT-PCR on a different set of P2 heterozygous control and *Blimp1* CKO retinas ([Figs. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}A, [2](#i1552-5783-58-2-1137-f02){ref-type="fig"}B). We examined one gene that decreased (*Rho*); three genes that were not significantly changed (*Otx2*, *Pax6*, and *Neurod1*); and nine genes that increased (*Cdh8*, *Fam19a3*, *Slitrk6*, *Fezf2*, *Samsn1*, *Lhx4*, *Tmem215*, *Trnp1*, and *Scgn*) by RNA-seq ([Fig. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}B). Most of these genes showed similar changes by RT-PCR except for *Cdh8* (unchanged) and *Otx2* (slight decrease; [Fig. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}A). The small statistically significant decrease in *Otx2* was likely due to the unusually small variance from the RT-PCR replicates ([Fig. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}A), while the discordance in *Cdh8* ([Figs. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}A, [2](#i1552-5783-58-2-1137-f02){ref-type="fig"}B) could represent a false positive from the RNA-seq analysis. However, since *Cdh8* has been shown to be expressed in type 2 cone OFF bipolar cells,^[@i1552-5783-58-2-1137-b46]^ it is more likely that the RT-PCR result represents a false negative result. On the whole, these data indicate that our RNA-seq assay can robustly detect precociously expressed bipolar cell-specific genes.

![Experimental design. Mice lacking *Blimp1* precociously form bipolar cells at the expense of photoreceptors starting around birth. We collected retinas from *αPax6-Cre::Blimp1^Flox/+^* heterozygous control (*green*) and *αPax6-Cre::Blimp1^Flox/Flox^* conditional knockout (*red*) mice at P2 for gene expression profiling. The transgene *αPax6-Cre* drives recombination in roughly half of the retina (*arrows*), leaving the central region un-recombined (wild-type). We collected RNA from whole retinas and subjected to RNA-seq analysis. By comparing expression values in mutants to heterozygous controls, we predict that upregulated genes will mark precocious developing bipolar cells and downregulated genes to mark photoreceptors. Since there are few bipolar genes expressed at P2 in wild-type retinas, this assay is especially sensitive to detect upregulated genes (i.e., early bipolar-specific factors). In contrast, the presence of photoreceptors in the P2 retina diminishes the power to detect downregulated genes.](i1552-5783-58-2-1137-f01){#i1552-5783-58-2-1137-f01}
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Genes Downregulated in *Blimp1* CKO Retinas
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Genes Upregulated in *Blimp1* CKO Retinas
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![Precociously upregulated gene expression in P2 *Blimp1* CKO retinas. (**A**, **B**) Gene expression quantification. Expression of several known and novel bipolar-specific candidate genes measured by RT-PCR (**A**) and RNA-seq (**B**). There is good agreement between these methods, with the exception of *Cdh8*, which was increased by RNA-seq, but not RT-PCR. *Otx2* is unchanged by RNA-seq, but is modestly lower by RT-PCR. As progenitor, ganglion, and amacrine cell numbers are grossly equivalent between *Blimp1* heterozygous and CKO animals, we did not expect to see changes in *Pax6* or *Neurod4* expression. The rod specific gene *Rho* is decreased in mutants as expected, while known bipolar genes *Lhx4*, *Fezf2*, and *Scgn* are increased. \* *P* \< 0.05. \*\* *P* \< 0.01. (**C**--**F**) In situ hybridization (*red*) of four candidate bipolar-specific genes in P2 *Blimp1* CKO retinas. DAPI (*blue*) staining is cropped to show retinal structure. The central (C) retina is left and the peripheral (P) retina is toward the right. The *dotted line* marks the approximate edge of *Blimp1* deletion. (**C**) *Tmem215* signal is extensive in the peripheral *Blimp1* CKO retina and is absent from the ganglion cell layer (GCL). The signal in the central retina is sparse. (**D**) Expression of *Gsg1* is modest in the peripheral retina and is essentially absent centrally and within the GCL. (**E**) *Trnp1* is widely expressed throughout the peripheral retina. It is expressed in the GCL in both peripheral and central retina. (**F**) Expression of *Slitrk6* is robust in the peripheral retina, while little signal is seen centrally. *Scale bar*: 100 μm for each panel.](i1552-5783-58-2-1137-f02){#i1552-5783-58-2-1137-f02}

We next examined upregulated candidate genes from the RNA-seq screen ([Table 2](#i1552-5783-58-2-1137-t02){ref-type="table"}) by immunohistochemistry and in situ hybridization in P2 *Blimp1* CKO retinas ([Figs. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}C--F and data not shown). We limited our analysis to four of these candidate bipolar-specific genes (*Tmem215*, *Gsg1*, *Trnp1*, and *Slitrk6*). Expression of *Tmem215* was sparsely observed in the central (wild-type) regions of P2 *Blimp1* CKO retinas ([Fig. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}C). As predicted from the RNA-seq data, there was considerably more signal in the peripheral (mutant) areas of these retinas ([Fig. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}C). Signal was absent from the RPE and the ganglion cell layer (GCL), consistent with expression in precocious nascent bipolar cells ([Fig. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}C). *Gsg1* was essentially absent from the central retina, but robustly expressed in the mutant peripheral retina ([Fig. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}D). Expression was more modest than *Tmem215* and absent from the RPE and GCL, consistent with expression in bipolar cells ([Fig. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}D). Expression of *Trnp1* was seen in the central and peripheral retina ([Fig. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}E). Expression levels in the GCL were roughly equal across the retina, while expression in the rest of the developing retina was conspicuously higher in the peripheral retina ([Fig. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}E). This pattern is most consistent with *Trnp1* expression in multiple cell types, including bipolar cells. Expression of *Slitrk6* was observed sparsely in the central retina and more robustly in the peripheral areas of P2 *Blimp1* CKO retinas ([Fig. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}F). There was a modest signal in the GCL, but most of the expression in the peripheral retina was consistent with precocious bipolar cell localization ([Fig. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}F). The increased expression of all four of these genes corresponded to the *Blimp1* mutant area of the retina, where it appeared to label a greater number of cells. These data suggest that *Slitrk6*, *Gsg1*, *Trnp1*, and *Tmem215* are expressed by bipolar cells. Further characterization of each of these genes is detailed below.

Slitrk6 and Gsg1 Are Expressed by a Subpopulation of Bipolar Cells {#s3b}
------------------------------------------------------------------

We examined *Slitrk6* and *Gsg1* expression both at P5 and in the mature retina where bipolar cells and their subtypes can be readily distinguished. After the in situ process, we immunostained sections with cell type--specific antibodies ([Fig. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}). At P5, we observed *Slitrk6* expression only in the central area of the wild-type retina ([Fig. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}A). This overlapped extensively, but not completely, with the bipolar marker Otx2 ([Table 3](#i1552-5783-58-2-1137-t03){ref-type="table"}; [Fig. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}A). No appreciable signal was seen in wild-type retinas at younger ages, suggesting that *Slitrk6* expression in bipolar cells starts at P5. Expression of *Slitrk6* in the adult retina has been previously examined by in situ hybridization, but the signal was diffuse in the GCL and inner nuclear layer (INL), and not precisely localized to any given cell type.^[@i1552-5783-58-2-1137-b47]^ Consistent with these observations, we observed relatively sparse *Slitrk6* expression within the INL and GCL ([Figs. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}B--D). Colabeling showed that some of the *Slitrk6* signal in the INL overlapped with Otx2, consistent with bipolar cell identity ([Fig. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}B). *Slitrk6* signal in the INL and GCL partially overlapped with calretinin, a marker of multiple amacrine and RGC subpopulations^[@i1552-5783-58-2-1137-b48]^ ([Fig. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}C). We did not observe *Slitrk6* overlap with Sox2, a marker of Müller glia and cholinergic amacrine cells^[@i1552-5783-58-2-1137-b49][@i1552-5783-58-2-1137-b50]--[@i1552-5783-58-2-1137-b51]^ ([Fig. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}D). These data indicate that *Slitrk6* is made by a subset of bipolar and amacrine cells, and perhaps by a subset of RGCs. We were unable to further investigate these subtypes because the in situ protocol for *Slitrk6* (see methods) was incompatible with nearly all of our cell type--specific antibodies.

![Bipolar cells labeled with *Slitrk6* and *Gsg1*. (**A**--**D**) Postnatal day 5 (**A**) and adult (**B**--**D**) wild-type retinas labeled for *Slitrk6* mRNA (*red*) and cell-type specific markers (*gray*/*green*). (**A**) At P5, *Slitrk6* signal (*red*) is seen in the central (C), but not peripheral (P) retina. Most of the *Slitrk6* signal overlaps with Otx2 (*green*, *arrows*, *insets*) while the remaining signal in the inner retina does not (*arrowheads*). Nuclear counterstaining with DAPI is cropped for clarity. (**B**) *Slitrk6* signal in the adult INL overlaps highly with the bipolar cell marker Otx2 (*green*, *arrows*, *insets*). Some *Slitrk6* signal in the INL does not overlap with Otx2 (*arrowheads*), consistent with amacrine cell identity. *Slitrk6* is also seen in the GCL, where it likely indicates amacrine and/or ganglion cell identity. Orthogonal XZ and YZ views are shown *below* and to the *right* with *blue lines* highlighting the X and Y positions. (**C**) Expression of *Slitrk6* partially overlaps with the amacrine and ganglion cell marker calretinin (*gray*; *arrows*, *insets*). *Arrowheads* mark *Slitrk6*+ cells that are located in the inner aspect of the INL that do not express calretinin, which are likely amacrine cells. (**D**) *Slitrk6* (*arrowheads*) does not overlap with Sox2, which marks Müller glia and starburst amacrines. Together, these results suggest that *Slitrk6* marks a subset of bipolars, amacrines, and possibly ganglion cells. (**E**--**H**) Postnatal day 5 (**E**) and adult (**F**--**H**) wild-type retinas labeled for *Gsg1* mRNA (*red*) and cell-type specific markers (*gray*/*green*). (**E**) At P5, *Gsg1* signal (*red*) shows a central to peripheral gradient. The *Gsg1* signal overlaps extensively with Otx2 (*green*, *arrows*, *insets*). Nuclear staining with DAPI is cropped for clarity. (**F**) *Gsg1* is sparse in the adult retina and is limited to the INL where it overlaps with Otx2 (*green*, *arrows*, *insets*). This suggests that *Gsg1* marks a subpopulation of bipolar cells. The orthogonal views are as above. (**G**) *Gsg1* overlaps highly with Scgn+ cone bipolar cells (*green*, *arrows*, *insets*), but not PKCα+ rod bipolar cells (*gray*, *insets* only). Approximately 30% of the Scgn+ bipolars contain *Gsg1* signal. (**H**) *Gsg1* overlaps highly with Cabp5 (*green*, *arrows*, *insets*), but only 21% of the Cabp5+ cells have an overlapping *Gsg1* signal. *Arrowheads* mark the occasional cell that appears Cabp5 negative. These results suggest that *Gsg1* marks types 3 and/or type 5 cone bipolar cells. *Scale bars*: 50 μm for (**A**--**E**) and (**F**--**H**); 10 μm for insets in (**A**--**E**) and (**F**--**H**).](i1552-5783-58-2-1137-f03){#i1552-5783-58-2-1137-f03}

###### 

Bipolar Cell Markers Used in This Study

![](i1552-5783-58-2-1137-t03)

We did not observe *Gsg1* signal in the wild-type retina until P5, where it showed a central to peripheral gradient of expression ([Fig. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}E). *Gsg1* signal was sparse and colocalized with Otx2 ([Fig. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}E). In the adult retina, *Gsg1* expression was tightly limited to a small number of cells in the outer half of the INL, where bipolar cells reside ([Figs. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}F--H). *Gsg1* signal appeared to overlap with Otx2 expression, suggesting that *Gsg1* is bipolar-specific ([Fig. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}F). We next costained *Gsg1* hybridized sections with a panel of bipolar subtype-specific markers ([Table 3](#i1552-5783-58-2-1137-t03){ref-type="table"}). As with *Slitrk6*, most of our antibodies were incompatible with *Gsg1* in situ hybridization. Nonetheless, we were able to colabel sections with the rod bipolar marker PKCα^[@i1552-5783-58-2-1137-b52]^ and with Scgn, which labels several subtypes of cone bipolar cells^[@i1552-5783-58-2-1137-b53]^ ([Table 3](#i1552-5783-58-2-1137-t03){ref-type="table"}; [Fig. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}G). We did not observe *Gsg1* signal in PKCα+ rod bipolars, but rather it appeared that the *Gsg1* signal overlapped extensively with Scgn ([Fig. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}G). This suggests that *Gsg1* labels types 2 to 6 cone bipolar cells ([Table 3](#i1552-5783-58-2-1137-t03){ref-type="table"}). Since only a subset of the Scgn+ bipolar cells were labeled (29.7% ± 4.8% SD), it is likely that *Gsg1* is made by one or two bipolar subtypes. To further narrow down which subtypes are labeled by *Gsg1*, we costained with Cabp5, a marker of rod bipolars and types 3 and 5 cone bipolars^[@i1552-5783-58-2-1137-b54]^ ([Table 3](#i1552-5783-58-2-1137-t03){ref-type="table"}; [Fig. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}H). It appeared that the *Gsg1* signal overlapped highly with Cabp5 ([Fig. 3](#i1552-5783-58-2-1137-f03){ref-type="fig"}H), but only a subset (20.9% ± 2.3% S.D) of the Cabp5+ cells contained *Gsg1* signal. Together, these data argue that *Gsg1* preferentially labels type 3 and/or type 5 cone bipolar cells ([Table 4](#i1552-5783-58-2-1137-t04){ref-type="table"}). We were unable to further discriminate between these subtypes due to incompatibility between the in situ protocol and our other antibodies.

###### 

Bipolar Cell Subsets Marked by Gsg1, Trnp1, and Tmem215

![](i1552-5783-58-2-1137-t04)

Trnp1 Marks ON Type Bipolar Cells in the Mouse Retina {#s3c}
-----------------------------------------------------

Owing to the limits of immunostaining following in situ hybridization, we used a well-characterized antibody^[@i1552-5783-58-2-1137-b44]^ to better track Trnp1 expression in the retina. We started by immunostaining wild-type retinas from several embryonic time-points, but none showed any detectable Trnp1 staining (data not shown). We next examined wild-type retinas at postnatal time-points. From P0 to P5, we did not observe any Trnp1 expression in the retina ([Figs. 4](#i1552-5783-58-2-1137-f04){ref-type="fig"}A, [4](#i1552-5783-58-2-1137-f04){ref-type="fig"}B, and data not shown). This contrasts with the in situ data from P2 *Blimp1* CKO retinas, which showed *Trnp1* signal in the GCL. This raises the possibility that Trnp1 expression in the GCL is below the detection threshold of this antibody, the in situ signal is spurious, or that *Trnp1* mRNA is not translated at these stages. Starting around P7, nuclear-localized Trnp1 signal was abundant in the INL of the retina ([Fig. 4](#i1552-5783-58-2-1137-f04){ref-type="fig"}C). We costained with Otx2 to mark bipolar cells and with Pax6 to mark other cell types in the INL^[@i1552-5783-58-2-1137-b12],[@i1552-5783-58-2-1137-b14],[@i1552-5783-58-2-1137-b55]^ at P7, P10, and in adult retinas ([Figs. 4](#i1552-5783-58-2-1137-f04){ref-type="fig"}C--E). At all stages, Trnp1 nuclear staining overlapped with Otx2, but not Pax6 ([Figs. 4](#i1552-5783-58-2-1137-f04){ref-type="fig"}C--E, 4J). Every Trnp1 cell expressed Otx2, but only approximately 53% of Otx2+ bipolar cells made Trnp1 ([Fig. 4](#i1552-5783-58-2-1137-f04){ref-type="fig"}J). Next, we looked at bipolar subtype-specific markers ([Table 3](#i1552-5783-58-2-1137-t03){ref-type="table"}). All of the Trnp1+ cells coexpressed Isl1/2, a marker of cone ON and rod bipolar cells^[@i1552-5783-58-2-1137-b25],[@i1552-5783-58-2-1137-b26]^ ([Fig. 4](#i1552-5783-58-2-1137-f04){ref-type="fig"}F). We then stained for PKCα and Scgn to mark rod bipolars and types 2 through 6 cone bipolars, respectively. Consistent with the Isl1/2 results, we observed that only a subset of Scgn+ cone bipolars coexpressed Trnp1 (28.1% ± 8.7% SD) ([Figs. 4](#i1552-5783-58-2-1137-f04){ref-type="fig"}G, [4](#i1552-5783-58-2-1137-f04){ref-type="fig"}J). Nearly all of the PKCα+ rod bipolars expressed Trnp1 (89.4% ± 9.6% SD) ([Figs. 4](#i1552-5783-58-2-1137-f04){ref-type="fig"}G, [4](#i1552-5783-58-2-1137-f04){ref-type="fig"}J). We found that Trnp1 did not appreciably overlap with the cone OFF bipolar markers Bhlhb5, PKARIIβ,^[@i1552-5783-58-2-1137-b56]^ and Calsenilin (Csen)^[@i1552-5783-58-2-1137-b57]^ ([Figs. 4](#i1552-5783-58-2-1137-f04){ref-type="fig"}H--J and data not shown). Taken together, these data suggest that Trnp1 is expressed early in bipolar cell maturation by all ON type bipolar cells in the retina ([Table 4](#i1552-5783-58-2-1137-t04){ref-type="table"}).

![Trnp1 marks ON type bipolar cells. Immunostaining of developing and adult retinas with Trnp1 (*green*) and cell type-specific markers. (**A**--**E**) Trnp1 costaining with Otx2 (*red*) and Pax6 (*gray*) at multiple ages. Otx2 is cropped and Pax6 shown only in the insets for clarity. At P0 (**A**) and P5 (**B**), no Trnp1 immunostaining is detected in the retina. (**C**) Starting at P7, Trnp1 nuclear staining is seen in the INL, where it overlaps completely with Otx2 (*arrows*, *insets*). The same pattern of Trnp1 expression is seen at P10 (**D**) and in adult (**E**) sections. Pax6+ amacrine cells in the ONL (*arrowheads*, *insets*) do not coexpress Trnp1 at any age. (**F**--**K**) Adult sections stained with Trnp1 and bipolar subtype specific markers (*red*/*gray*). (**F**) Cells that are Trnp1+ coexpress Isl1/2 (*red*, *arrows*, *insets*), which marks ON type bipolar cells in the retina. Starburst amacrines labeled by Isl1/2 (*arrowheads*) do not express Trnp1. (**G**--**G\'\'**) A section showing Trnp1, Scgn (*gray*) and PKCα (*red*) costaining. A subset of Trnp1+ cells coexpresses Scgn (*arrowheads*, *insets*) or PKCα (*arrows*, *insets*). Nearly all of the PKCα+ rod bipolar cells express Trnp1 (G\'\'), but only a fraction of Scgn+ cone bipolars are Trnp1+ (**G\'**). (**H**) Type 2 cone OFF bipolar cells marked by Bhlhb5 staining (*arrowheads*, *insets*) do not coexpress Trnp1. Bhlhb5+ amacrine cells are marked with an "a". (**I**) Calsenilin-positive type 4 cone OFF bipolar cells (*arrowheads*, *insets*) do not coexpress Trnp1. *Scale bars*: (**A**--**E**, **G**--**H**) 25 μm for panels and 10 μm for insets; (**F**) 100 μm and 10 μm for insets; (**I**) 50 μm and 10 μm for the insets. (**J**) Quantification of Trnp1 staining in the adult wild-type retina. The *left panel* shows the fraction of Trnp1+ cells that coexpress a cell-type specific marker. The *right panel* shows what percentage of a given population of cells expresses Trnp1. *Error bars* represent SD.](i1552-5783-58-2-1137-f04){#i1552-5783-58-2-1137-f04}

Tmem215 Is Expressed by a Complex Subset of Bipolar and Amacrine Cells {#s3d}
----------------------------------------------------------------------

We conducted *Tmem215* in situ hybridization on P5, P10, and adult wild-type retinas. At P5, the *Tmem215* signal was limited to the nascent INL, with higher intensity in the outer aspect where bipolar cells reside ([Fig. 5](#i1552-5783-58-2-1137-f05){ref-type="fig"}A). By P10, a strong band of Tmem215 signal was seen in the outer portion of the INL ([Fig. 5](#i1552-5783-58-2-1137-f05){ref-type="fig"}B). In adult mice, the *Tmem215* signal labeled a subset of cells in the outer and inner portions of the INL, consistent with bipolar and amacrine cell labeling ([Fig. 5](#i1552-5783-58-2-1137-f05){ref-type="fig"}C). Due to incompatibilities with antibodies, we sought a different approach to label Tmem215. We acquired a *Tmem215-LacZ* gene trap knock-in line from the KOMP Repository.^[@i1552-5783-58-2-1137-b37]^ These mice are designed to express β-gal in the *Tmem215* pattern. To test this, we first crossed *Tmem215-LacZ* animals to *Blimp1* CKO mice and immunostained for β-gal and Blimp1. At P2, we observed a strong upregulation of β-gal expression in the peripheral (mutant) retina ([Fig. 5](#i1552-5783-58-2-1137-f05){ref-type="fig"}D). We did not observe β-gal+ cells in the central-most (wild-type) retina or that coexpressed Blimp1 ([Fig. 5](#i1552-5783-58-2-1137-f05){ref-type="fig"}D). We observed rare, weakly β-gal+ cells in the central retina of P4 *Tmem215-LacZ* mice (data not shown); but by P5, robust β-gal expression was seen in a central to peripheral gradient, mimicking the progression of bipolar cell development ([Fig. 5](#i1552-5783-58-2-1137-f05){ref-type="fig"}E). Staining with β-gal was equivalent to the *Tmem215* in situ pattern, with most of the β-gal expression in the bipolar cell area and fewer instances of amacrine cells ([Fig. 5](#i1552-5783-58-2-1137-f05){ref-type="fig"}E). In adult *Tmem215-LacZ* mice, β-gal+ cells were localized to the INL ([Fig. 5](#i1552-5783-58-2-1137-f05){ref-type="fig"}F). The majority (∼90%) of β-gal+ cells coexpressed Otx2 and a smaller fraction (∼9%) coexpressed the amacrine marker Pax6 ([Figs. 5](#i1552-5783-58-2-1137-f05){ref-type="fig"}F, [6](#i1552-5783-58-2-1137-f06){ref-type="fig"}J). These β-gal+ cells only represented approximately 39% of the Otx2+ bipolar and 8% of the amacrine cell populations ([Figs. 5](#i1552-5783-58-2-1137-f05){ref-type="fig"}F, [6](#i1552-5783-58-2-1137-f06){ref-type="fig"}J).

![*Tmem215-LacZ* mimics *Tmem215* expression in the retina. (**A**--**C**) *Tmem215* in situ hybridization (*red*) in wild-type retinas. Nuclear counterstaining with DAPI (*blue*) is cropped for clarity. (**A**) *Tmem215* signal in the central P5 retina is localized to the area of the retina containing bipolar cells and amacrines. (**B**) By P10, *Tmem215* signal is strongly localized to the INL (inset). (**C**) In the adult retina, *Tmem215* clusters signal in the outer INL (*arrows*, *inset*) suggest bipolar cell staining while less frequent clusters in the inner INL indicate amacrine identity (*arrowheads*, *inset*). (**D**--**F**) *Tmem215-LacZ* knock-in mice stained for β-galactosidase (*green*). (**D**) Postnatal day 2 *Blimp1 CKO::Tmem215-LacZ* transgenic retina. Central (C) is to the left while peripheral (P) is right. Blimp1 immunostaining (*red*) shows substantial deletion right of the dotted line. There are more β-gal+ cells (*arrows*) in the *Blimp1* deleted peripheral region, mimicking the *Tmem215* in situ data ([Fig. 2](#i1552-5783-58-2-1137-f02){ref-type="fig"}). None of the β-gal+ cells in any region coexpresses Blimp1. (**E**) In P5 *Tmem215-LacZ* heterozygous mice, β-gal+ cells are localized in the future INL and primarily show bipolar cell morphology (*arrows*). A few cells with amacrine morphology are seen (*arrowheads*) and there is a central-to-peripheral gradient of β-gal expression, mimicking the normal developmental progression of bipolar cell genesis. (**F**) In adults, β-gal+ cells are localized to the INL. Most of the β-gal+ cells coexpress Otx2 (*red*) (*arrows*, *blue insets*) while a smaller population coexpresses Pax6 (*gray*, *arrowheads*, *white insets*). The *Tmem215-LacZ* transgene closely matches the *Tmem215* pattern. *Scale bars*: (**A**--**E**) 100 μm for panels and 10 μm for insets; (**F**) 50 μm for the panel and 10 μm for insets.](i1552-5783-58-2-1137-f05){#i1552-5783-58-2-1137-f05}

![Tmem215 marks subsets of bipolar and amacrine cells. Adult *Tmem215-LacZ* heterozygous mice stained for β-gal (*green*) and cell-type specific markers (*red*/*gray*). (**A**--**A\'**) Section stained with Scgn (*gray*) and PKCα (*red*). A large fraction of β-gal+ cells coexpress Scgn (*arrows*, *insets*), but none overlap with PKCα (*arrowheads*, *insets*). (**B**) Costaining with Scgn (*gray*) and Isl1/2 (*red*) to mark ON bipolar cells. A subset of β-gal+ cells coexpress Isl1/2 (*arrows*, *blue insets*). Other β-gal+ cells coexpress only Scgn (*arrowheads*), marking them as cone OFF bipolars. Thus, *Tmem215-LacZ* marks both ON and OFF cone bipolar cells. (**C**--**C\'**) Costaining with Isl1/2 (*gray*) and Vsx1 (*red*), which mark types 1, 2, and 7 cone bipolars. A subset of β-gal+ cells coexpress Vsx1 and Isl1/2 (*arrows*, *insets*), marking them as type 7 cone ON bipolars. However, not all type 7 cone bipolars were β-gal+ (*magenta arrowheads*, *insets*). Some β-gal+ cells expressed Isl1/2, but not Vsx1 (*arrowheads*, *insets*). Of the β-gal+ cells that did not express Isl1/2, none coexpressed Vsx1 (*asterisks*). This argues that types 1 and 2 cone bipolars are not Tmem215+. Isl1/2+ amacrine cells do not coexpress β-gal. (**D**) A subset of β-gal+ cells coexpress Cabp5 (*red*, *arrows*, *insets*), which marks types 3 and 5 cone bipolars. (**E**) β-gal costaining with HCN4 to mark type 3a cone OFF bipolars. Most HCN4+ bipolar cells coexpress β-gal (*arrows*, *insets*), though some HCN4+ cells in the inner INL lack β-gal staining (*arrowheads*). (**F**) β-gal expression (*arrowheads*, *insets*) does not overlap with PKARIIβ (*red*), a marker of type 3b cone bipolars. (**G**) Type 2 cone OFF bipolars marked with Bhlhb5 did not express β-gal (*arrowheads*, *insets*). We did not see β-gal overlap with the type 4 cone OFF bipolar marker Csen (data not shown). (**H**--**H\'**) Retinas stained with the amacrine markers GlyT1 (*red*, glycinergic) and GAD65/67 (*gray*, GABAergic). Roughly equal fractions coexpress GlyT1 (*arrows*, *insets*) and GAD65/67 (*arrowheads*, *insets*). There are no β-gal+ displaced amacrine cells seen. (**I**) A subset of the β-gal+ amacrine cells (*arrowheads*, *insets*) coexpress Ap2α (*red*) (*arrows*, *insets*). *Scale bars*: 50 μm for panels and 10 μm for insets. (**J**) Quantification of β-gal+ cells. The *left panel* shows the percentage of β-gal+ cells that coexpress a cell type--specific marker. There are approximately 9 β-gal+ bipolar cells (Otx2+) for every amacrine cell (Pax6+). The *right panel* shows the fraction of a cell type--specific marker population that coexpresses β-gal+. *Error bars* show SD.](i1552-5783-58-2-1137-f06){#i1552-5783-58-2-1137-f06}

To define which bipolar and amacrine subtypes expressed Tmem215, we costained adult *Tmem215-LacZ* heterozygous mice for β-gal and several subtype-specific markers ([Table 3](#i1552-5783-58-2-1137-t03){ref-type="table"}; [Fig. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}). We observed that a large subset of β-gal + cells coexpressed Scgn (72.2% ± 5.5% SD), though not all Scgn+ cells were β-gal+ ([Figs. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}A, [6](#i1552-5783-58-2-1137-f06){ref-type="fig"}J). This suggests that Tmem215 marks mostly types 2 through 6 cone bipolar cells in addition to other bipolar subtypes. Immunostaining for PKCα did not reveal any appreciable overlap with β-gal, arguing that rod bipolars do not express Tmem215 ([Fig. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}A\'). Next, we immunostained sections with Isl1/2 to label ON type bipolars and with either Scgn or Vsx1 to mark subsets containing both ON and OFF cone bipolar subtypes ([Table 3](#i1552-5783-58-2-1137-t03){ref-type="table"}; [Figs. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}B--C). We observed that the majority (63.0% ± 4.9% SD) of β-gal+ cells coexpressed Isl1/2, indicating that they are mostly cone ON bipolar cells ([Figs. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}B, [6](#i1552-5783-58-2-1137-f06){ref-type="fig"}C, [6](#i1552-5783-58-2-1137-f06){ref-type="fig"}J). We observed that β-gal+ bipolars coexpressed Isl1/2 and Scgn or just Isl1/2, indicating that Tmem215 marks cone ON bipolar subtypes in addition to just types 5 and 6 (that are marked by Scgn; [Fig. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}B). This also indicates that Tmem215 labels at least some of the types 2 through 4 cone OFF bipolar cells. A fraction of the β-gal+ bipolar cells coexpressed Vsx1, which marks types 1, 2, and 7 cone bipolars^[@i1552-5783-58-2-1137-b28]^ ([Figs. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}C, [6](#i1552-5783-58-2-1137-f06){ref-type="fig"}J). However, these β-gal+/Vsx1+ cells always coexpressed Isl1/2, indicating that they are type 7 cone ON bipolar cells and not types 1 or 2 OFF bipolars ([Fig. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}C). Not all type 7 cone ON bipolars expressed β-gal ([Fig. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}C\'). We next examined Cabp5 expression, which marks rod bipolars and types 3 and 5 cone bipolars. Since rod bipolars were not found to express β-gal, we expected that only a subset of the Cabp5+ cells would coexpress β-gal ([Fig. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}D). Indeed, only 33% of the Cabp5+ cells made β-gal, whereas 46% of the β-gal+ cells made Cabp5, suggesting that types 3 and 5 cone bipolar cells express Tmem215 ([Figs. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}D, [6](#i1552-5783-58-2-1137-f06){ref-type="fig"}J). We next used antibodies to HCN4 to mark type 3a cone OFF bipolar cells and small subset of amacrines^[@i1552-5783-58-2-1137-b56],[@i1552-5783-58-2-1137-b58]^ ([Table 3](#i1552-5783-58-2-1137-t03){ref-type="table"}; [Fig. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}E). We observed that approximately 22% of the β-gal+ cells coexpressed HCN4 ([Figs. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}E, [6](#i1552-5783-58-2-1137-f06){ref-type="fig"}J). As was the case with type 7 cells, not all of the HCN4+ cells in the INL were colabeled with β-gal (63.3% ± 10.4% +SD; [Fig. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}E). We then costained β-gal+ cells with markers of the remaining three cone OFF bipolar populations ([Table 3](#i1552-5783-58-2-1137-t03){ref-type="table"}); PKARIIβ (type 3b); Bhlhb5 (type 2); and Csen (type 4) ([Figs. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}F, [6](#i1552-5783-58-2-1137-f06){ref-type="fig"}G). There was no appreciable overlap of β-gal with PKARIIβ ([Fig. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}F), Bhlhb5 ([Fig. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}G), or Csen (not shown and [Fig. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}J) indicating that Tmem215 does not mark types 2, 3b, or 4 cone OFF bipolar cells. Taken together, these combinations of marker overlap suggest that Tmem215 marks type 3a cone OFF bipolar cells and types 5, 6, and 7 cone ON bipolars ([Table 4](#i1552-5783-58-2-1137-t04){ref-type="table"}). We were unable to distinguish between the three type 5 bipolar cell subtypes. Nor were we able to specifically mark type 6, 8, 9, or XBC bipolar cells. Since there are Isl1/2+ cone ON bipolars that make β-gal, but not Scgn, it is possible that type 8, 9, or XBCs also express Tmem215 ([Table 4](#i1552-5783-58-2-1137-t04){ref-type="table"}). We observed some variability in the number of β-gal+ cells between animals, suggesting that β-gal expression does not mark all Tmem215+ cells. This may explain why some type 3a cone OFF bipolars (HCN4+) and type 7 cone ON bipolars (Vsx1+/Isl1/2+) did not coexpress β-gal. Alternatively, only subsets of these bipolar subtypes might express Tmem215.

Lastly, we looked at amacrine cell subtypes that express Tmem215. We costained adult *Tmem215-LacZ* heterozygous retinas with β-gal and three broad amacrine subtype markers ([Figs. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}H--J). We observed that approximately half of the β-gal+ amacrine population expressed GlyT1, a marker of glycinergic amacrine cells^[@i1552-5783-58-2-1137-b48],[@i1552-5783-58-2-1137-b59]^ ([Figs. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}H, [6](#i1552-5783-58-2-1137-f06){ref-type="fig"}J). Similarly, approximately half of the β-gal+ cells coexpressed GAD65/67, which marks GABAergic amacrines^[@i1552-5783-58-2-1137-b48]^ ([Figs. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}H\', 6J). Lastly, approximately a third of the β-gal+ amacrines expressed Ap2α, a marker of a large complex set of amacrine subtypes in the retina^[@i1552-5783-58-2-1137-b60]^ ([Figs. 6](#i1552-5783-58-2-1137-f06){ref-type="fig"}I, [6](#i1552-5783-58-2-1137-f06){ref-type="fig"}J). Together, these data indicate that Tmem215 marks multiple subtypes of amacrine cells in the retina. We found Tmem215 does not mark any displaced amacrine subtypes, since all of the β-gal+ cells have their somas in the INL.

Discussion {#s4}
==========

The mechanisms that govern bipolar interneuron fate choice and subtype identity are only partially understood. The transcription factor *Blimp1* represses bipolar cell fate choice during retinal development.^[@i1552-5783-58-2-1137-b15],[@i1552-5783-58-2-1137-b35],[@i1552-5783-58-2-1137-b36]^ We took advantage of precocious bipolar cell development in *Blimp1* CKO mice to screen for novel pan- and subtype-specific developmental markers of bipolar cells. From this, we identified several genes that have not been characterized during bipolar cell genesis. Of the genes we examined in more detail (*Slitrk6*, *Gsg1*, *Trnp1*, and *Tmem215*), each marked a different subpopulation of bipolar cells. The expression patterns of several other precociously upregulated genes from our study, such as *Cnpy1* and *Samsn1*, remain to be characterized. Based on the spatial specificity of the genes we have tested to date, it is likely that many of the remaining candidates will show bipolar subtype-specific expression. Thus, precociously expressed bipolar-specific genes may function as novel regulators of class and subtype fate choice. Whether *Slitrk6*, *Gsg1*, *Trnp1*, and *Tmem215* control bipolar cell development remains to be tested.

Slitrk6 and Gsg1 Proteins {#s4a}
-------------------------

Slitrk6 belongs to a family of single-pass transmembrane proteins characterized by their ability to affect neurite outgrowth.^[@i1552-5783-58-2-1137-b61]^ Messenger RNA expression of *Slitrk6* was previously detected in the mature INL and GCL of the mouse retina,^[@i1552-5783-58-2-1137-b47]^ similar to what we observed. Other data suggest that *Slitrk6* is made earlier in development,^[@i1552-5783-58-2-1137-b62],[@i1552-5783-58-2-1137-b63]^ though we saw little signal in the retina at P2 or younger stages. This may be due to the use of different in situ probes and hybridization techniques. Humans with homozygous *SLITRK6* nonsense mutations display high (i.e., severe) myopia and sensorineural deafness.^[@i1552-5783-58-2-1137-b47]^ Mice with a *Slitrk6* mutation have similar phenotypes, but also show delayed maturation of ribbon synapses in the outer plexiform layer. This implies that Slitrk6 expression in bipolar cells is important for synapse formation and/or maturation.^[@i1552-5783-58-2-1137-b47]^ The apparent expression of *Slitrk6* by only a subset of bipolar cells may explain why the ribbon synapse phenotype in *Slitrk6* knockout mice is relatively mild. Better tools are needed to precisely characterize which subtypes of bipolars, amacrines, and possibly ganglion cells express *Slitrk6*. This information will be important for fully understanding how *Slitrk6* regulates retinal development and physiology.

The expression pattern of *Gsg1* has not been characterized previously in the mouse retina. Prior work showed that the amount of *Gsg1* transcription was decreased in retinas that lacked *Otx2* (loss of bipolar cells).^[@i1552-5783-58-2-1137-b64]^ Conversely, *Blimp1* mutant mice showed increased *Gsg1* (and several other genes we observed) expression by microarray analysis at P6,^[@i1552-5783-58-2-1137-b36]^ a time when wild-type bipolar cells are normally differentiating. Together, these data are consistent with our findings that *Gsg1* is bipolar cell--specific. Starting around P5, we observed *Gsg1* mRNA in a small subset of bipolar cells. The in situ pattern of *Gsg1* was most consistent with expression in types 3 and/or 5 cone bipolars. While we cannot rule out that other cone bipolar subtypes make *Gsg1*, the sparse in situ pattern suggests that only one or two subtypes are labeled. Little is known about *Gsg1* expression and function. It has been best characterized in spermatids, where it appears to be an endoplasmic reticulum (ER)-localized membrane protein.^[@i1552-5783-58-2-1137-b65]^ Gsg1 interacts with testis-specific poly A polymerase (TPAP), sequestering it to the ER. This localization of TPAP may be required for spermatid maturation.^[@i1552-5783-58-2-1137-b65],[@i1552-5783-58-2-1137-b66]^ In the retina, Gsg1 may affect mRNA polyadenylation within specific bipolar cell subtypes to uniquely control their physiology or development. The precise expression pattern and function of *Gsg1* in the retina remains to be tested.

TMF-Regulated Nuclear Protein {#s4b}
-----------------------------

Initially, Trnp1 was characterized in immortalized cell lines. This 223 amino acid nuclear-localized protein promotes cell cycle progression of cultured cells.^[@i1552-5783-58-2-1137-b67]^ More recently, Trnp1 expression has been described in the developing cerebral cortex.^[@i1552-5783-58-2-1137-b44],[@i1552-5783-58-2-1137-b68],[@i1552-5783-58-2-1137-b69]^ Expression of Trnp1 was seen in neural stem cells.^[@i1552-5783-58-2-1137-b44],[@i1552-5783-58-2-1137-b68]^ Gain- and loss-of-function experiments in the mouse cerebral cortex showed that high levels of Trnp1 promotes neural stem cell self-renewal and tangential expansion. In contrast, lower levels of Trnp1 promote radial expansion, with increased intermediate progenitors and basal radial glial cells leading to the folding of the otherwise smooth murine cerebral cortex.^[@i1552-5783-58-2-1137-b44],[@i1552-5783-58-2-1137-b68]^ Thus, Trnp1 acts like a master regulator of neural stem cell fate. In addition to neural stem cells, Trnp1 is also transiently expressed in postmitotic cortical neurons.

Based on our RNA-seq experiments and the findings in cortex, we expected to see *Trnp1* in bipolar cells and progenitors. We observed modest *Trnp1* mRNA expression by in situ hybridization in the developing retina, but it was primarily localized to the ganglion cell layer that is devoid of any progenitor cells. We did not observe any Trnp1 immunostaining in wild-type retinas until P7, where it specifically and permanently marked bipolar cells. This discordance between mRNA and protein labeling could be due to nonspecific signal detection from the in situ hybridization protocol. However, since there was a modest number of *Trnp1* RNA-seq reads in control retinas at P2, Trnp1 protein may be below the threshold of antibody detection or the mRNA may not be translated until later time-points. While Trnp1 immunostaining labeled only ON type bipolar cells in the adult retina, a small seemingly random population of these bipolars was Trnp1 negative. This further suggests that Trnp1 immunostaining is not completely sensitive.

Trnp1 regulates neural stem cell fate choice in the developing cortex; however, the onset of Trnp1 protein expression in the retina at P7 suggests that it influences bipolar cell maturation or physiology instead of subtype fate choice. This may also be the case in the cortex, where Trnp1 is expressed by newly formed neurons. While the exact cellular functions of Trnp1 are unknown, it has been localized to euchromatin in the nucleus, suggesting that it promotes gene expression.^[@i1552-5783-58-2-1137-b44],[@i1552-5783-58-2-1137-b67]^ This raises the possibility that Trnp1 functions downstream of subtype fate choices in the retina by activating the expression of genes important for ON bipolar function, such as *Grm6* (mGluR6) and *Gnao* (Goα). Trnp1 may synergize with or act downstream of Isl1, a transcription factor that is also expressed by ON type bipolar cells.^[@i1552-5783-58-2-1137-b25],[@i1552-5783-58-2-1137-b26]^ Loss-of-function studies are ongoing to test whether *Trnp1* controls subtype choice in the retina or ON bipolar physiology. These studies will also reveal whether *Trnp1* plays an earlier role in retinal development.

Tmem215 Expression {#s4c}
------------------

Using RNA-seq, in situ hybridization and a *LacZ* knock-in mouse line, we characterized *Tmem215* expression in the developing retina. However, these techniques yielded slightly different results. Sequencing of RNA on control P2 retinas suggested that *Tmem215* was expressed at very low levels or in only a few cells. Few if any β-gal+ cells were seen in *Tmem215-LacZ* mice at P2. In contrast, *Tmem215* in situ hybridization signal occasionally yielded a broader expression pattern at P2. Starting at P5, the *Tmem215* in situ hybridization signal and the β-gal+ immunostaining patterns were equivalent. Thus, there may be nonspecific in situ probe binding at P2 when there are few *Tmem215* transcripts available. In the mature retina, *Tmem215-LacZ* marked a complex subset of cone bipolar cells and amacrines. We observed that types 3a, 5, and 7 cone bipolars expressed β-gal and that types 1, 2, 3b, and 4 lacked β-gal staining. We were unable to determine definitively whether the remaining cone bipolar subtypes were β-gal positive or negative. Not every type 3a, 5, or 7 cone bipolar made β-gal. This suggests that there is either additional subtype diversity in these populations or that β-gal expression was below the threshold of detection. In support of the latter, we observed modest variability in the number of β-gal+ cells between *Tmem215-LacZ* animals. The types of bipolars that coexpressed β-gal did not change between animals suggesting that the *Tmem215-LacZ* gene trap allele incompletely labels specific subsets of cone bipolar cells. Further supporting our findings, transcriptome profiling of sorted bipolar cells showed that *Tmem215* expression is enriched in bipolar cells compared to other retinal cell types.^[@i1552-5783-58-2-1137-b70]^

Since Tmem215 expression starts early in bipolar cell development, it could play a role in bipolar cell subtype fate choice, maturation, and/or physiology. Little is known about how *Tmem215* functions. It is a predicted transmembrane protein that may interact with MAGI1, a protein localized to cell junctions.^[@i1552-5783-58-2-1137-b71][@i1552-5783-58-2-1137-b72][@i1552-5783-58-2-1137-b73]--[@i1552-5783-58-2-1137-b74]^ MAGI1 can influence cell signaling events, thus Tmem215 may mediate transduction of cell-cell signals during bipolar genesis to regulate subtype fate choice. It has also been shown that MAGI1 is important for synapse formation in *Caenorhabditis elegans*,^[@i1552-5783-58-2-1137-b75]^ where it helps shuttle ionotropic glutamate receptors to synapses. As these receptors are seen in OFF type bipolar cells, Tmem215 may regulate synaptic maturation and/or function. Since Tmem215 is expressed by both ON and OFF bipolar cells, it may regulate common physiologic features of these subtypes. Alternatively, Tmem215 may regulate different functions in each subtype. This is analogous to Vsx1, which controls gene expression differently in ON versus OFF cone bipolar cells.^[@i1552-5783-58-2-1137-b28]^ Comparing bipolar cell development between homozygous *Tmem215-LacZ* gene trap mice and heterozygous controls will distinguish between these possibilities.
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